Methylxanthines Increase Renal Calcium Excretion in Preterm Infants
Biology of the Neonate · 30.09.2009 · 169-174
DOI: 10.1159/000244234 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Biology of the Neonate, online erschienen am 30.09.2009. Verfasst von V Zanardo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Padova School of Medicine, Italy. Die Arbeit wurde bisher 56-mal zitiert (Crossref).
Themen: Neonatologie
Abstract (Originalsprache)
To determine the effect of a short course of methylxanthines on renal function and on urinary calcium excretion, 20 premature neonates affected by apnea or moderate respiratory distress syndrome were randomly assigned to either a theophylline treatment or to a caffeine treatment group. The protocol included a 24-hour pretreatment study period (I) and a subsequent 24-hour period (II) following 5 days of theophylline (loading dose 5 mg/kg i.v., maintenance dose 2.5 mg/kg/l2 h) or caffeine (loading dose 10 mg/kg i.v., maintenance dose 2.5 mg/kg/l2 h) administration. Pre- and postxanthine treatment serum sodium, potassium, calcium and phosphorus remained stable, while serum creatinine decreased significantly (p < 0.05). Furthermore, from period I to period II, sodium urine excretion, fractional Na excretion and creatinine clearance remained statistically comparable in both study groups, along with a significant increase (p < 0.05) in calciuria, urinary Ca/creatinine and urinary Ca/Na. Predose caffeine and theophylline serum levels, assessed on the 5th day of treatment, were 12.8 ± 1.8 and 7.9 ± 1.7 μg/ml, respectively. Compared to control healthy untreated prematures, the studied premature infants showed a statistically significant increase in urine calcium excretion (10- to 15-fold), which was more evident in the theophylline group. Our data suggest further investigation to determine the long-term renal effects of methylxanthines in premature neonates, to improve assessment of the risk of nephrocalcinosis and osteopenia, in particular in association with various diuretic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Padova School of Medicine, Italy.
Zitieren
APA
Zanardo, V., Dani, C., Trevisanuto, D., Meneghetti, S., Guglielmi, A., Zacchello, G., & Cantarutti, F. (2009). Methylxanthines Increase Renal Calcium Excretion in Preterm Infants. Biology of the Neonate, 169-174. https://doi.org/10.1159/000244234
Vancouver
Zanardo V, Dani C, Trevisanuto D, Meneghetti S, Guglielmi A, Zacchello G, et al. Methylxanthines Increase Renal Calcium Excretion in Preterm Infants. Biology of the Neonate. 2009:169-174. doi:10.1159/000244234
BibTeX
@article{Zanardo2009,
author = {Zanardo, V and Dani, C and Trevisanuto, D and Meneghetti, S and Guglielmi, A and Zacchello, G and Cantarutti, F},
title = {Methylxanthines Increase Renal Calcium Excretion in Preterm Infants},
journal = {Biology of the Neonate},
year = {2009},
pages = {169--174},
doi = {10.1159/000244234}
}
EUVIMED